(Q35696637)

English

Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections

scientific article published on March 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

0 references

author name string

Cribier BJ

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Bakshi R

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

150

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

414-420

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Epidemiology of onychomycosis in special-risk populations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Long-term efficacy of antifungals in toenail onychomycosis: a critical review

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Treatment of Candida nail infection with terbinafine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Safety of oral terbinafine for toenail onychomycosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2003.05726.X

21 January 2018

Identifiers

10.1046/J.1365-2133.2003.05726.X

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35696637&oldid=1697142441"